Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Amortization of Deferred Charges (2024 - 2025)

Historic Amortization of Deferred Charges for Kura Oncology (KURA) over the last 2 years, with Q3 2025 value amounting to $141000.0.

  • Kura Oncology's Amortization of Deferred Charges rose 522.39% to $141000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $552000.0, marking a year-over-year change of. This contributed to the annual value of $523000.0 for FY2024, which is 964.36% up from last year.
  • Latest data reveals that Kura Oncology reported Amortization of Deferred Charges of $141000.0 as of Q3 2025, which was up 522.39% from $138000.0 recorded in Q2 2025.
  • Kura Oncology's 5-year Amortization of Deferred Charges high stood at $141000.0 for Q3 2025, and its period low was $122000.0 during Q1 2024.